{"id":"https://openalex.org/W1968619342","doi":"https://doi.org/10.1001/archpsyc.60.4.386","title":"High Levels of Serotonin Transporter Occupancy With Low-Dose Clomipramine in Comparative Occupancy Study With Fluvoxamine Using Positron Emission Tomography","display_name":"High Levels of Serotonin Transporter Occupancy With Low-Dose Clomipramine in Comparative Occupancy Study With Fluvoxamine Using Positron Emission Tomography","alternate_titles":[],"publication_year":2003,"publication_date":"2003-04-01","ids":{"openalex":"https://openalex.org/W1968619342","doi":"https://doi.org/10.1001/archpsyc.60.4.386","mag":"1968619342","pmid":"https://pubmed.ncbi.nlm.nih.gov/12695316"},"language":"en","primary_location":{"id":"doi:10.1001/archpsyc.60.4.386","doi":"https://doi.org/10.1001/archpsyc.60.4.386","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archpsyc.60.4.386","pdf_url":null,"source":{"id":"https://openalex.org/S126359496","display_name":"Archives of General Psychiatry","issn_l":"0003-990X","issn":["0003-990X","1538-3636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of General Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1968619342"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://repo.qst.go.jp/records/43675","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085556975","display_name":"Tetsuya Suhara","orcid":"https://orcid.org/0000-0003-2916-225X","observed_orcids":["https://orcid.org/0000-0003-2916-225X"]},"institutions":[{"id":"https://openalex.org/I4387155384","display_name":"National Institute of Radiological Sciences","ror":"https://ror.org/05szqz470","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4387155384"]},{"id":"https://openalex.org/I4405287617","display_name":"Institute for Radiological Science","ror":"https://ror.org/05pbkxj36","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210114217","https://openalex.org/I4405287617"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Tetsuya Suhara","raw_affiliation_strings":["Brain Imaging Project, National Institute of Radiological Sciences, Chiba, Japan. suhara@nirs.go.jp","Brain Imaging Project, National Institute of Radiological Sciences, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brain Imaging Project, National Institute of Radiological Sciences, Chiba, Japan. suhara@nirs.go.jp","institution_ids":["https://openalex.org/I4387155384","https://openalex.org/I4405287617"]},{"raw_affiliation_string":"Brain Imaging Project, National Institute of Radiological Sciences, Chiba, Japan","institution_ids":["https://openalex.org/I4387155384","https://openalex.org/I4405287617"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062363884","display_name":"Akihiro Takano","orcid":"https://orcid.org/0000-0002-3034-7721","observed_orcids":["https://orcid.org/0000-0002-3034-7721"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akihiro Takano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108473037","display_name":"Yasuhiko Sudo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasuhiko Sudo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091490546","display_name":"Tetsuya Ichimiya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tetsuya Ichimiya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009964528","display_name":"Makoto Inoue","orcid":"https://orcid.org/0000-0002-3991-3806","observed_orcids":["https://orcid.org/0000-0002-3991-3806"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Makoto Inoue","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039339347","display_name":"Fumihiko Yasuno","orcid":"https://orcid.org/0000-0002-5981-5795","observed_orcids":["https://orcid.org/0000-0002-5981-5795"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fumihiko Yasuno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100989798","display_name":"Yoko Ikoma","orcid":"https://orcid.org/0000-0001-6312-2353","observed_orcids":["https://orcid.org/0000-0001-6312-2353"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoko Ikoma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5031416330","display_name":"Yoshiro Okubo","orcid":"https://orcid.org/0000-0003-1767-0230","observed_orcids":["https://orcid.org/0000-0003-1767-0230"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshiro Okubo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5085556975"],"corresponding_institution_ids":["https://openalex.org/I4387155384","https://openalex.org/I4405287617"],"apc_list":null,"apc_paid":null,"fwci":3.5226,"has_fulltext":false,"cited_by_count":133,"citation_normalized_percentile":{"value":0.91601773,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"60","issue":"4","first_page":"386","last_page":"386"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.5278000235557556,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.5278000235557556,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.44850000739097595,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serotonin-transporter","display_name":"serotonin transporter","score":0.8999999761581421},{"id":"https://openalex.org/keywords/clomipramine","display_name":"clomipramine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.6000000238418579},{"id":"https://openalex.org/keywords/low-dose-antidepressants","display_name":"low-dose antidepressants","score":0.7429999709129333},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.718999981880188},{"id":"https://openalex.org/keywords/thalamus","display_name":"thalamus","score":0.6769999861717224},{"id":"https://openalex.org/keywords/positron-emission-tomography","display_name":"positron emission tomography","score":0.40400001406669617},{"id":"https://openalex.org/keywords/effective-dose-estimation","display_name":"effective dose estimation","score":0.5600000023841858},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.5350000262260437},{"id":"https://openalex.org/keywords/nonspecific-binding","display_name":"non-specific binding","score":0.5979999899864197},{"id":"https://openalex.org/keywords/enantiomers","display_name":"enantiomers","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.7953852415084839},{"id":"https://openalex.org/C2779305415","wikidata":"https://www.wikidata.org/wiki/Q58713","display_name":"Clomipramine","level":2,"score":0.7227615714073181},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.574016809463501},{"id":"https://openalex.org/C2778897192","wikidata":"https://www.wikidata.org/wiki/Q410142","display_name":"Serotonin transporter","level":4,"score":0.5167481303215027},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.5120473504066467},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4790574014186859},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.4645628035068512},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.446214497089386},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38841572403907776},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.3736122250556946},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.32816222310066223},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.32134583592414856},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.1427178978919983},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002997","descriptor_name":"Clomipramine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002997","descriptor_name":"Clomipramine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002997","descriptor_name":"Clomipramine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013788","descriptor_name":"Thalamus","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D013788","descriptor_name":"Thalamus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013788","descriptor_name":"Thalamus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014055","descriptor_name":"Tomography, Emission-Computed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D026901","descriptor_name":"Membrane Transport Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D050486","descriptor_name":"Serotonin Plasma Membrane Transport Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1001/archpsyc.60.4.386","doi":"https://doi.org/10.1001/archpsyc.60.4.386","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archpsyc.60.4.386","pdf_url":null,"source":{"id":"https://openalex.org/S126359496","display_name":"Archives of General Psychiatry","issn_l":"0003-990X","issn":["0003-990X","1538-3636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of General Psychiatry","raw_type":"journal-article"},{"id":"pmid:12695316","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12695316","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of general psychiatry","raw_type":"Comparative Study"},{"id":"pmh:oai:irdb.nii.ac.jp:01116:0003807278","doi":null,"is_oa":true,"landing_page_url":"https://repo.qst.go.jp/records/43675","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Archives of General Psychiatry","raw_type":"journal article"},{"id":"pmh:oai:repo.qst.go.jp:00004562","doi":null,"is_oa":false,"landing_page_url":"http://repo.nirs.go.jp/?action=repository_uri&amp;item_id=4562","pdf_url":null,"source":{"id":"https://openalex.org/S4377196694","display_name":"QST-Repository (National Institutes for Quantum and Radiological Science and Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210114217","host_organization_name":"National Institutes for Quantum Science and Technology","host_organization_lineage":["https://openalex.org/I4210114217"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:irdb.nii.ac.jp:01116:0003807278","doi":null,"is_oa":true,"landing_page_url":"https://repo.qst.go.jp/records/43675","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Archives of General Psychiatry","raw_type":"journal article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1849830234","https://openalex.org/W1906659553","https://openalex.org/W1980532101","https://openalex.org/W1983638695","https://openalex.org/W1986988181","https://openalex.org/W1989845182","https://openalex.org/W1998438831","https://openalex.org/W2003817082","https://openalex.org/W2004018121","https://openalex.org/W2017651312","https://openalex.org/W2032377018","https://openalex.org/W2033885513","https://openalex.org/W2048308101","https://openalex.org/W2054061970","https://openalex.org/W2054929374","https://openalex.org/W2057383836","https://openalex.org/W2059003502","https://openalex.org/W2072069319","https://openalex.org/W2076639163","https://openalex.org/W2085769789","https://openalex.org/W2095253451","https://openalex.org/W2100444801","https://openalex.org/W2114177397","https://openalex.org/W2125228745","https://openalex.org/W2138575098","https://openalex.org/W2145458328","https://openalex.org/W2152769424","https://openalex.org/W2169396775","https://openalex.org/W2169568318","https://openalex.org/W2200711696","https://openalex.org/W2261633412","https://openalex.org/W2404341015","https://openalex.org/W2407474190","https://openalex.org/W2415495275","https://openalex.org/W2417034125","https://openalex.org/W2418856154","https://openalex.org/W2429715841"],"related_works":["https://openalex.org/W1980870198","https://openalex.org/W2129633806","https://openalex.org/W2128473988","https://openalex.org/W1989915234","https://openalex.org/W3199137132","https://openalex.org/W2136740172","https://openalex.org/W2125228745","https://openalex.org/W2078993378","https://openalex.org/W2028937236","https://openalex.org/W2897423680"],"abstract_inverted_index":{"CONTEXT:":[0],"Serotonin":[1],"transporters":[2],"(5-HTT)":[3],"are":[4,33],"regarded":[5],"as":[6,195],"one":[7],"of":[8,13,48,58,82,116,125,134,179,192,214,219,229,241,244,252,268,281,288,302,310],"the":[9,39,109,113,171,176,189,196,212],"major":[10],"therapeutic":[11],"targets":[12],"antidepressants.":[14],"However,":[15],"there":[16],"have":[17,294],"only":[18],"been":[19],"a":[20,45,223],"few":[21],"studies":[22,183],"about":[23],"5-HTT":[24,42,59,220,298,311],"occupancy,":[25,235],"and":[26,44,75,84,100,104,130,156,184,188,261,274,283,290],"in":[27,89,170,222,312],"particular,":[28],"data":[29,93,105,204],"concerning":[30],"classical":[31],"antidepressants":[32],"still":[34],"limited.":[35],"OBJECTIVE:":[36],"To":[37],"investigate":[38],"relationship":[40],"between":[41,96],"occupancy":[43],"wide":[46],"range":[47],"antidepressant":[49],"dosing":[50],"protocols.":[51],"DESIGN,":[52],"SETTING,":[53],"AND":[54],"PARTICIPANTS:":[55],"Antidepressant":[56],"occupancies":[57],"were":[60,72,87,94,106,139,146,173,209,271],"measured":[61,73],"using":[62,175],"positron":[63],"emission":[64],"tomography":[65],"(PET)":[66],"with":[67,74,78,239],"[11C](+)McN5652.":[68],"Twenty-seven":[69],"healthy":[70,193],"volunteers":[71,194],"without":[76],"pretreatment":[77],"single":[79,142],"low":[80],"doses":[81,86,124,133,145,280],"antidepressants,":[83],"long-term":[85],"evaluated":[88],"10":[90,227],"patients.":[91],"Scan":[92],"collected":[95],"December":[97],"12,":[98],"1995,":[99],"August":[101],"7,":[102],"2002,":[103],"analyzed":[107],"during":[108],"2001-2002":[110],"period":[111],"at":[112],"National":[114],"Institute":[115],"Radiological":[117],"Sciences":[118],"(Chiba,":[119],"Japan).":[120],"Intervention":[121],"Four":[122],"different":[123,132],"clomipramine":[126,154,230,253,282,303],"hydrochloride":[127,231,254,304],"(5-50":[128],"mg)":[129,138],"3":[131],"fluvoxamine":[135,164,245,269,284],"maleate":[136,270],"(12.5-50":[137],"used":[140,210],"for":[141,153,163,181,198,211,258,264],"administration.":[143],"Long-term":[144],"20":[147],"to":[148,158,307],"250":[149],"mg":[150,160,228,243,257,273],"per":[151,161],"day":[152,162],"hydrochloride,":[155],"25":[157],"200":[159],"maleate.":[165,246],"Main":[166],"Outcome":[167],"Measure":[168],"Occupancies":[169],"thalamus":[172],"calculated":[174],"individual":[177],"baseline":[178,197],"[11C](+)McN5652":[180],"single-dose":[182],"2":[185],"long-term-dose":[186,200],"studies,":[187],"mean":[190],"value":[191],"8":[199],"studies.":[201],"The":[202],"average":[203],"from":[205],"inactive":[206],"enantiomers":[207],"[11C](-)McN5652":[208],"estimation":[213],"nonspecific":[215],"binding.":[216],"RESULTS:":[217],"Occupancy":[218],"increased":[221],"curvilinear":[224],"manner.":[225],"Even":[226],"showed":[232],"approximately":[233,286],"80%":[234,287,309],"which":[236],"was":[237,255,305],"comparable":[238],"that":[240],"50":[242],"Estimated":[247],"median":[248],"effective":[249],"dose":[250,260,291],"(ED50)":[251],"2.67":[256],"oral":[259],"1.42":[262],"ng/mL":[263],"plasma":[265],"concentration;":[266],"those":[267],"18.6":[272],"4.19":[275],"ng/mL,":[276],"respectively.":[277],"CONCLUSIONS:":[278],"Clinical":[279],"occupied":[285],"5-HTT,":[289],"escalation":[292],"would":[293],"minimal":[295],"effect":[296],"on":[297],"blockade.":[299],"Ten":[300],"milligrams":[301],"enough":[306],"occupy":[308],"vivo.":[313]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1968619342","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
